Cichocki Meghan N, Chung William T, Kane Robert L, Chung Kevin C
Section of Plastic Surgery, Michigan Medicine, Ann Arbor, MI, USA.
J Hand Surg Eur Vol. 2023 Feb;48(2):123-130. doi: 10.1177/17531934221133992. Epub 2022 Nov 3.
Multiple treatment options are available to patients with Dupuytren contracture, making shared decision-making complex. Our rigorous qualitative analysis sought to understand patient perceptions of shared decision-making in Dupuytren contracture treatment and create a conceptual framework to optimize patient-physician communication. We interviewed 30 patients with Dupuytren contracture to learn about their experience with treatment selection. The following themes were integral to shared decision-making for Dupuytren contracture treatment: discussing disease progression and treatment initiation, presenting all available treatment options, assessing patients' pre-existing biases towards treatment, patient values and preferences for treatment trade-offs, treatment risks and benefits, physician recommendation and active patient participation. This model can optimize communication about treatment options and expectations for relevant outcomes including, recovery time, contracture recurrence, complications, and treatment-related expenses. V.
患有掌腱膜挛缩症的患者有多种治疗选择,这使得共同决策变得复杂。我们进行了严谨的定性分析,旨在了解患者对掌腱膜挛缩症治疗中共同决策的看法,并创建一个概念框架以优化医患沟通。我们采访了30名掌腱膜挛缩症患者,以了解他们在治疗选择方面的经历。以下主题对于掌腱膜挛缩症治疗的共同决策至关重要:讨论疾病进展和治疗开始时机、介绍所有可用的治疗选择、评估患者对治疗的既有偏见、患者对治疗权衡的价值观和偏好、治疗风险和益处、医生建议以及患者的积极参与。该模型可以优化关于治疗选择以及对相关结果(包括恢复时间、挛缩复发、并发症和治疗相关费用)期望的沟通。五。